Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Rahim M Naimi, Mark Hvistendahl, Lotte H Enevoldsen, Jan L Madsen, Stefan Fuglsang, Steen Seier Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj Nerup, Rikard Ambrus, Michael P Achiam, Lars B Svendsen, Jens Juul Holst, Bolette Hartmann, Svend H Hansen, Lars Ove Dragsted, Adam Steensberg, Ulrik Mouritzen, Mark B Hansen, Palle Bekker Jeppesen

15 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science